News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Criminal IP Reveals Global React2Shell RCE Exposure Across React Server Components News Civic Roundtable launches with the Georgia Technology Authority (GTA), continuing its expansion across the US News Dental Digital Launches Marketing Services for Dental Practices News Gammil Law Announces Jury Awarding $16 Million In Teacher Sexual Abuse Case News Law Mother Announces the Launch of Wealthy Ever After – a Roadmap for Building Generational Wealth News 8JJ Group Announces Launch of Innovative Digital Platform to Unite Cricket Fans Across South Asia Ahead of 2026 Season
